rs13333553
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_001009944.3(PKD1):c.8644T>A(p.Trp2882Arg) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00877 in 1,599,366 control chromosomes in the GnomAD database, including 1,050 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/19 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Consequence
NM_001009944.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -20 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
PKD1 | NM_001009944.3 | c.8644T>A | p.Trp2882Arg | missense_variant | 23/46 | ENST00000262304.9 | NP_001009944.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
PKD1 | ENST00000262304.9 | c.8644T>A | p.Trp2882Arg | missense_variant | 23/46 | 1 | NM_001009944.3 | ENSP00000262304.4 |
Frequencies
GnomAD3 genomes AF: 0.0469 AC: 7130AN: 152152Hom.: 553 Cov.: 31
GnomAD3 exomes AF: 0.0118 AC: 2759AN: 233310Hom.: 212 AF XY: 0.00872 AC XY: 1127AN XY: 129210
GnomAD4 exome AF: 0.00476 AC: 6894AN: 1447096Hom.: 497 Cov.: 34 AF XY: 0.00396 AC XY: 2853AN XY: 720446
GnomAD4 genome AF: 0.0469 AC: 7139AN: 152270Hom.: 553 Cov.: 31 AF XY: 0.0450 AC XY: 3350AN XY: 74472
ClinVar
Submissions by phenotype
not provided Benign:3
Benign, criteria provided, single submitter | clinical testing | Athena Diagnostics | Oct 23, 2017 | - - |
Benign, criteria provided, single submitter | clinical testing | GeneDx | Oct 11, 2019 | This variant is associated with the following publications: (PMID: 17574468, 17582161, 22008521) - |
Likely benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
not specified Benign:1
Benign, criteria provided, single submitter | clinical testing | PreventionGenetics, part of Exact Sciences | - | - - |
Polycystic kidney disease, adult type Benign:1
Benign, criteria provided, single submitter | clinical testing | ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories | Dec 17, 2019 | - - |
Polycystic kidney disease Benign:1
Benign, no assertion criteria provided | clinical testing | Department of Pathology and Laboratory Medicine, Sinai Health System | - | The PKD1 p.Trp2882Arg variant is identified in the literature in 3 of 716 proband chromosomes (frequency: 0.004) as a polymorphism from individuals or families with ADPKD, but it was not identified in 442 control chromosomes from healthy individuals (Bataille 2011, Rossetti 2007, Garcia-Gonzalez 2007). In addition the PKD1 p.Glu2966Asp variant was reported as co-occurring with 2 pathogenic PKD1 variants (1470A>G, Y420C and 4262C>T, R1351W) in a proband (Garcia-Gonzalez_2007). The variant was also identified in dbSNP (ID: rs13333553) as “With Benign allele”, Clinvitae (as benign), ClinVar (as benign, by Prevention Genetics), ADPKD Mutation Database (as likely neutral). This variant was identified in the 1000 Genomes Project in 254 of 5008 chromosomes (frequency: 0.050), the NHLBI GO Exome Sequencing Project in 6 of 7794 European American alleles (freq: 0.0007) and in 515 of 3964 African American alleles (freq: 0.13), the genome Aggregation Database (beta, October 19th 2016) in 3124 (239 homozygous) of 236960 chromosomes (freq. 0.013), the Exome Aggregation Consortium database (August 8th 2016) in 1510 (122 homozygous) of 112386 chromosomes (freq. 0.013) in the following populations: African in 1403 of 8206 chromosomes (freq. 0.171), Latino in 80 of 11338 chromosomes (freq. 0.007), other in 5 of 832 chromosomes (freq. 0.006), South Asian in 6 of 16338 chromosomes (freq. 0.0003), and European in 16 of 60860 chromosomes (freq. 0.0002), but was not seen in East Asian and Finnish populations. The variant was identified by our laboratory in 2 individuals with ADPKD, co-occurring with a pathogenic PKD1 variant (c.3489delC, p.Phe1163Leufsx8 and c.2494dupC, p.Arg832ProfsX40), increasing the likelihood that the p.Trp2882Arg variant does not have clinical significance. The p.Trp2882Arg variant was not identified in the PKD1-LOVD, PKD1-LOVD 3.0, COGR and HAPMAP databases. The p.Trp2882 residue is not conserved in mammals and other organisms and four out of five computational analyses (PolyPhen-2, SIFT, AlignGVGD, BLOSUM, MutationTaster) do not suggest a high likelihood of impact to the protein; however, this information is not predictive enough to rule out pathogenicity. The variant occurs outside of the splicing consensus sequence and 1 of 5 in silico or computational prediction software programs (SpliceSiteFinder, MaxEntScan, NNSPLICE, GeneSplicer, HumanSpliceFinder) predict a greater than 10% difference in splicing; this is not very predictive of pathogenicity. In summary, based on the above information, this variant meets our laboratory criteria to be classified as benign. - |
Autosomal dominant polycystic kidney disease Benign:1
Likely benign, criteria provided, single submitter | research | Molecular Genetics of Inherited Kidney Disorders Laboratory, Garvan Institute of Medical Research | Jan 01, 2019 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at